Kereena chukka (8 Ergebnisse)
- Softcover
Anbieter: Books Puddle, New York, NY, USABooks Puddle
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Neu
EUR 122,32
EUR 3,46 VersandVersand innerhalb von USAAnzahl: 4 verfügbar
Zustand: New.
- Weitere Bilder
- Softcover
Anbieter: preigu, Osnabrück, Deutschlandpreigu
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 67,20
EUR 70,00 VersandVersand von Deutschland nach USAAnzahl: 5 verfügbar
Taschenbuch. Zustand: Neu. Immunity and Genetic Polymorphisms of Head and Neck Cancer | Kereena Chukka | Taschenbuch | 172 S. | Englisch | 2018 | Scholars' Press | EAN 9786202315470 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
- Weitere Bilder
- Softcover
- Print-on-Demand
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, DeutschlandBuchWeltWeit Ludwig Meier e.K.
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 79,90
EUR 23,00 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experience…s. Searching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes. 172 pp. Englisch.
- Weitere Bilder
- Softcover
- Print-on-Demand
Anbieter: moluna, Greven, Deutschlandmoluna
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 64,09
EUR 48,99 VersandVersand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Chukka KereenaDr.Kereena Chukka has done her PhD in Head and Neck Cancer biology from the Department of Biotechnology, Acharya Nagarjuna University, Guntur, India. She has been published 25 research paper…s in reputed scientific journ.
- Softcover
- Print-on-Demand
Anbieter: Majestic Books, Hounslow, Vereinigtes KönigreichMajestic Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Neu
EUR 125,64
EUR 7,60 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 4 verfügbar
Zustand: New. Print on Demand.
- Softcover
- Print-on-Demand
Anbieter: Biblios, frankfurt am main, HESSE, DeutschlandBiblios
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Neu
EUR 128,64
EUR 9,95 VersandVersand von Deutschland nach USAAnzahl: 4 verfügbar
Zustand: New. PRINT ON DEMAND.
- Weitere Bilder
- Softcover
- Print-on-Demand
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschlandbuchversandmimpf2000
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 79,90
EUR 60,00 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. S…earching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 172 pp. Englisch.
- Weitere Bilder
- Softcover
- Print-on-Demand
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 80,86
EUR 61,37 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Diagnosis of Head and Neck Cancer (HNC) presents a multifarious problem. Late stage diagnosis, functional loss resulting in reduced Quality of Life, fear, stress, malnutrition and uncertainty throughout the cancer treatment experiences. Se…arching of biomarkers specific for high risk tumors in early stages is really essential. In the present study, we identified the prevalence of HNC was 45.2% underscoring an urgent need to better understand the biological bases of this type of cancer in this region. We chose to address this challenge by studying the role of antioxidative, immune markers, and XRCC1 DNA repair gene in HNC patients. Dietary protein supplementation to Head and Neck Cancer cases undergoing treatment had a beneficial effect by improving their nutrient intakes, anthropometric status, antioxidative and immune markers of the HNC patients. Cancer cases by offering good protection to normal cells, which may further reduce the risk of developing secondary cancers. CD44 appears to be a fair marker of HNC and to have potential diagnostic value, because its detection is easy in terms of final outcomes.
